---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-031441"
form_type: "8-K"
ticker: "HCWB"
cik: "0001828673"
company_name: "HCW Biologics Inc."
filed_at: "2026-07-01T12:30:14+00:00"
generated_at: "2026-07-01T12:35:22.194976+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# HCW Biologics settles $2.8M in disputed payables; lien removed, EirGenix obligation cleared

## Summary
- Settlement extinguishes $2.8 million in disputed accounts payable, reported in Q2 ending June 30, 2026.
- B&I Contractors dismissed crossclaims with prejudice and filed satisfaction of $1.1M mechanics' lien on company property.
- Company paid $1.24M to EirGenix under settlement reducing original $1.7M obligation; final payment on May 26, 2026.
- Two $620k payments (March 3 and May 26, 2026) fully settled disputed EirGenix manufacturing costs.
- All outstanding amounts related to these disputes are fully resolved with no remaining liabilities.

## SEC filing metadata
- accession: 0001493152-26-031441
- form_type: 8-K
- ticker: HCWB
- cik: 0001828673
- company_name: HCW Biologics Inc.
- filed_at: 2026-07-01T12:30:14+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1828673/000149315226031441/0001493152-26-031441-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1828673/000149315226031441/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-031441
- JSON: https://secwatch.observer/filing/0001493152-26-031441.json
- Plain text: https://secwatch.observer/filing/0001493152-26-031441.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.